JAKE LUNDQUIST: Open Payments
NPI 1396348280 · BLAIRSVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,048 in 49 payments from 19 companies in 2025. Trend: 2023 $583 · 2024 $448 · 2025 $1,048
Food & beverage: $690Consulting: $313Education: $45
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $457 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $98 |
| Lilly USA, LLC | 3 | $77 |
| Corcept Therapeutics | 3 | $54 |
| Novo Nordisk Inc | 3 | $45 |
| PFIZER INC. | 3 | $44 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $40 |
| SCPHARMACEUTICALS INC. | 2 | $31 |
| Amgen Inc. | 2 | $28 |
| ACADIA Pharmaceuticals Inc | 1 | $24 |
Products named: CAPLYTA, VRAYLAR, Korlym, Rybelsus, XIFAXAN, UBRELVY, MOUNJARO, FUROSCIX.
Industry payments across GA — which companies pay providers there.
